Skip to main content
. 2023 Aug 24;131(8):087017. doi: 10.1289/EHP12500

Table 2.

Description of biomarkers (μg/g creatinine) in gestational urine samples.

Biomarker Abbreviation Healthy Start analytic sample (n=438)a Healthy Start subset (n=24)b Roggeman et al.36,c
LOD (μg/L) Percentage detected (%) Percentile ICC ICC
25th 50th 75th
Phthalates
 Mono-ethyl phthalate MEP 0.6 99.8 16.0 34.6 99.9 0.60 0.45
 Mono-benzyl phthalate MBzP 0.3 97.3 2.3 5.6 12.6 0.48 0.48
 Mono-3-carboxypropyl phthalate MCPP 0.2 96.3 1.1 2.1 4.2 0.23 0.21
 Mono carboxyisooctyl phthalate MCOP 0.2 100.0 8.5 18.6 48.0 0.25 0.26
 Mono carboxyisononyl phthalate MCNP 0.2 99.1 1.9 3.1 5.6 0.18 0.08
 Mono-n-butyl phthalate MnBP 0.4 96.6 5.1 11.2 18.3 0.04 0.43
 Mono-hydroxybutyl phthalate MHBP 0.4 72.1 0.6 1.2 2.0 0.52
ΣDi-n-butyl phthalate metabolitesd ΣDBP 5.6 12.3 20.1 0.00
 Mono-isobutyl phthalate MiBP 0.2 98.9 3.9 8.2 14.4 0.59 0.42
 Mono-hydroxyisobutyl phthalate MHiBP 0.4 95.4 2.2 3.8 6.3 0.57
ΣDi-isobutyl phthalate metabolitese ΣDiBP 6.3 12.1 20.2 0.61
 Mono-2-ethylhexyl phthalate MEHP 0.5 72.8 0.5 1.2 2.5 0.58 0.28
 Mono-2-ethyl-5-hydroxyhexyl phthalate MEHHP 0.2 99.3 2.5 5.0 10.2 0.28 0.21
 Mono-2-ethyl-5-oxohexyl phthalate MEOHP 0.2 99.1 2.6 4.7 8.9 0.31 0.24
 Mono-2-ethyl-5-carboxypentyl phthalate MECPP 0.2 100.0 6.8 11.2 20.4 0.39 0.28
ΣDi(2-ethylhexyl) phthalate metabolitesf ΣDEHP 13.6 24.1 43.3 0.36
Phenols
 2,4 dichlorophenol 0.1 96.1 0.4 0.6 1.2 0.74
 2,5 dichlorophenol 0.1 95.0 0.8 1.8 5.7 0.84
 Bisphenol A BPA 0.1 97.7 0.6 1.1 1.9 0.39 0.20
 Bisphenol S BPS 0.1 87.0 0.2 0.3 0.6 0.25 0.20
 Benzophenone-3 0.2 99.5 36.3 110.3 438.9 0.86
 Methyl paraben 1.0 100.0 47.8 142.5 343.4 0.82 0.47
 Propyl paraben 0.1 100.0 5.2 27.6 95.0 0.79 0.49
 Triclosan 1.0 92.7 4.6 15.3 63.4 0.83

Note: Biomarkers are creatinine-standardized based on the O’Brien method.19 ICC, intraclass correlation coefficient; LOD, limit of detection.

a

Analytic sample of the Healthy Start cohort conducted during 2009–2014 enrolled participants who provided a urine sample midpregnancy and had at least one time point with outcome assessment.

b

Subset within Healthy Start cohort conducted during 2009–2014 enrolled participants who provided at least three urine samples in mid-to-late pregnancy.

c

Mean value calculated from the 2022 review by Roggeman et al.36 on variability in urine biomarkers of nonpersistent chemical exposures. Mean values calculated only for studies of pregnancy, and preferentially limited to creatinine or specific-gravity standardized ICCs when multiple ICCs were provided in one study. Missing ICCs are for biomarkers without values provided in the review. See Tables S3 and S4 for more details.

d

Sum of di-n-butyl phthalate metabolites: MnBP and MHBP.

e

Sum of di-isobutyl phthalate metabolites: MiBP and MHiBP.

f

Sum of di(2-ethylhexyl) phthalate metabolites: MEHP, MEOHP, MEHHP, and MECPP.